Recent studies identify CD147-positive EVs as promising biomarkers for detecting colorectal neoplasia, advanced adenocarcinoma, and early-stage CRC, outperforming the fecal immunochemical test (FIT) in identifying precancerous lesions and proximal neoplasia (140). The gene discussed is BSG; the disease is colorectal carcinoma.